Seasoned investor and operator with a focus on growth-stage technology and healthcare companies, offering board and executive-level experience to institutional and venture investors. Linda Roitman has background in corporate finance, strategic M&A and portfolio company scaling, and frequently serves on boards or as an advisor to startups. Markets view her as a pragmatic capital allocator who supports revenue-driven growth and governance improvements.
Seasoned investor and operator with a focus on growth-stage technology and healthcare companies, offering board and executive-level experience to institutional and venture investors. Linda Roitman has background in corporate finance, strategic M&A and portfolio company scaling, and frequently serves on boards or as an advisor to startups. Markets view her as a pragmatic capital allocator who supports revenue-driven growth and governance improvements.
Prioritizes growth-stage technology and healthcare investments where board-level operational support accelerates revenue scaling. Focuses on capital-efficient rounds that de-risk through measurable commercial traction, repeatable go-to-market models and disciplined financial governance. Combines strategic M&A lens with hands-on portfolio work to drive exits over a three- to seven-year horizon, favoring companies with durable unit economics, strong leadership teams and clear paths to profitable scale.
Prioritizes growth-stage technology and healthcare investments where board-level operational support accelerates revenue scaling. Focuses on capital-efficient rounds that de-risk through measurable commercial traction, repeatable go-to-market models and disciplined financial governance. Combines strategic M&A lens with hands-on portfolio work to drive exits over a three- to seven-year horizon, favoring companies with durable unit economics, strong leadership teams and clear paths to profitable scale.
| Trades 62 | Longs Won 39/62 62% | Profit Factor 3.76 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $3.82M |
| Average Win $2.89M | Best Trade (Mar 31) $14.99M | Sharpe Ratio -41.37 |
| Average Loss -$1.3M | Worst Trade (Dec 30) -$5.44M | Z-Score 1.25 (79.01%) |
| Commissions $0 | Avg. Trade Length 9m 2w 1d | Expectancy $1.34M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.67% |
| Consecutive Losing Trades | 201 | 181 | 161 | 141 | 121 | 100 | 80 | 60 | 40 | 20 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
BKR Baker Hughes Company | 737,194 | $33.27M | $40.16M | - | $6.89M | 20.7% | -1.616% |
BWXT Bwx Technologies Inc. | 192,407 | $34.2M | $25.59M | - | -$8.61M | -25.19% | -1.071% |
DKS Dick's Sporting Goods, Inc. | 99,808 | $20.57M | $13.84M | - | -$6.72M | -32.69% | +1.278% |
HSIC Henry Schein, Inc. | 694,183 | $48.74M | $59.97M | - | $11.23M | 23.04% | +0.97% |
IWM iShares Russell 2000 ETF | 29,300 | $8.4M | $7.96M | - | -$437,262.05 | -5.21% | +0.123% |
SHC Sotera Health Company | 2.03M | $28.39M | $36.09M | - | $7.7M | 27.1% | +0.282% |
TECH Bio-Techne Corporation | 120,000 | $8.48M | $8.7M | - | $223,800 | 2.64% | +0.021% |
VAC Marriott Vacations Worldwide Corporation | 644,610 | $45.7M | $69.38M | - | $23.68M | 51.8% | +1.318% |